Immuneering Corporation (IMRX)
NASDAQ · Healthcare
Immuneering Corporation Income Statement 2020–2023
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenue | 0 | 316,952 | 2.1M | 2.3M |
| Gross Profit | 0 | 158,830 | 926,888 | 1.0M |
| Profitability | ||||
| Operating Income | -58.4M | -51.7M | -33.9M | -17.1M |
| EBITDA | -58.1M | — | — | — |
| Net Income | -53.5M | -50.5M | -33.5M | -17.0M |
| Per Share Data | ||||
| EPS (diluted) | — | — | — | — |
| Shares Outstanding (dil.) | 28M | 26M | 14M | 5M |
Immuneering Corporation Income Statement — FAQ
Immuneering Corporation (IMRX) income statement over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IMRX's income statement history?
The chart and table above show Immuneering Corporation's income statement by year and by quarter, including the growth rate.